Delivery Order SPE2DB22D2005-SPE2DB25FJDX1
Award Date
10/21/24
Potential Completion Date
10/22/24
Potential Value
$9.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Vyvanse capsules, 30mg, to the Defense Logistics Agency (DLA). The $16,721.57 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of 4,566,708,453 units of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,626.84 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 12, 2024 with a completion date of December 13, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Vyvanse 50mg capsules in 100-count bottles to the Defense Logistics Agency (DLA). The $4,992.76 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 19, 2024. The contract has an ultimate completion date of November 20, 2024 and was not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
The federal contract award is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA), a major defense agency of the U.S. government. The $3,488.60 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor. This contract is a child of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award is for the delivery of Vyvanse capsules (40mg) to the Defense Logistics Agency (DLA), a defense agency. The $34,466.34 firm-fixed-price delivery order contract has a period of performance through May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
This federal contract award is for the delivery of Vyvanse 40 mg capsules (100 count) to the Defense Logistics Agency (DLA). The $1,337.70 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 23, 2024, with a completion date of December 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award is for the delivery of Vyvanse 30 mg capsules (100s) to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense. The $3,530.51 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025 with a completion date of March 18, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of 10mg Vyvanse capsules, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,783.60, is a firm-fixed price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of December 6, 2024 and is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Vyvanse 60 mg capsules in 100 count packages, awarded to AmerisourceBergen Drug Corp. The $1,462.91 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of November 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...